2/5
06:10 am
tvrd
Tvardi Therapeutics (NASDAQ:TVRD) was upgraded by analysts at Lucid Cap Mkts from a "hold" rating to a "strong-buy" rating.
Medium
Report
Tvardi Therapeutics (NASDAQ:TVRD) was upgraded by analysts at Lucid Cap Mkts from a "hold" rating to a "strong-buy" rating.
1/8
07:05 pm
tvrd
Tvardi Therapeutics Announces Further Phase 2 REVERT IPF Data, Expanding Clinical Insights [Yahoo! Finance]
Medium
Report
Tvardi Therapeutics Announces Further Phase 2 REVERT IPF Data, Expanding Clinical Insights [Yahoo! Finance]
1/8
04:56 pm
tvrd
Tvardi Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
Medium
Report
Tvardi Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference [Yahoo! Finance]
1/8
04:05 pm
tvrd
Tvardi Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
Medium
Report
Tvardi Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
1/8
08:00 am
tvrd
Tvardi Therapeutics Announces Further Phase 2 REVERT IPF Data, Expanding Clinical Insights
High
Report
Tvardi Therapeutics Announces Further Phase 2 REVERT IPF Data, Expanding Clinical Insights
1/6
01:33 am
tvrd
Tvardi Therapeutics (NASDAQ:TVRD) was upgraded by analysts at
Wall Stree
Low
Report
Tvardi Therapeutics (NASDAQ:TVRD) was upgraded by analysts at
Wall Stree
12/29
01:07 am
tvrd
Tvardi Therapeutics (NASDAQ:TVRD) was downgraded by analysts at
Wall Str
Medium
Report
Tvardi Therapeutics (NASDAQ:TVRD) was downgraded by analysts at
Wall Str
12/24
11:23 am
tvrd
TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
Low
Report
TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
12/23
10:18 am
tvrd
INVESTIGATION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
Low
Report
INVESTIGATION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
12/21
10:11 am
tvrd
TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
Neutral
Report
TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
12/21
01:08 am
tvrd
Tvardi Therapeutics (NASDAQ:TVRD) was upgraded by analysts at
Wall Stree
Neutral
Report
Tvardi Therapeutics (NASDAQ:TVRD) was upgraded by analysts at
Wall Stree
12/20
08:01 am
tvrd
SHAREHOLDER INVESTOR REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
Neutral
Report
SHAREHOLDER INVESTOR REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
12/17
10:31 am
tvrd
TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
Medium
Report
TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
12/11
10:15 am
tvrd
TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
Low
Report
TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
12/4
10:28 am
tvrd
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
Low
Report
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
12/3
09:50 am
tvrd
TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
Medium
Report
TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
11/30
09:46 am
tvrd
TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
Medium
Report
TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
11/29
08:51 am
tvrd
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
Medium
Report
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
11/25
01:58 pm
tvrd
Tvardi Therapeutics (NASDAQ:TVRD) had its "sell (e)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Tvardi Therapeutics (NASDAQ:TVRD) had its "sell (e)" rating reaffirmed by analysts at
Weiss Ratings.
11/21
10:08 am
tvrd
TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
Low
Report
TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
11/20
02:36 pm
tvrd
TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
Low
Report
TVRD INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Tvardi Therapeutics
11/18
01:22 pm
tvrd
Tvardi Therapeutics (NASDAQ:TVRD) had its "sell (e)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Tvardi Therapeutics (NASDAQ:TVRD) had its "sell (e)" rating reaffirmed by analysts at
Weiss Ratings.
11/18
08:00 am
tvrd
Tvardi Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference
Medium
Report
Tvardi Therapeutics to Participate in the Piper Sandler 37th Annual Healthcare Conference
11/14
10:31 am
tvrd
SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at Tvardi
Medium
Report
SHAREHOLDER INVESTIGATION: Faruqi & Faruqi, LLP Examining Potential Securities Law Violations at Tvardi
11/12
01:30 pm
tvrd
Tvardi Therapeutics (NASDAQ:TVRD) had its "sell (e)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Tvardi Therapeutics (NASDAQ:TVRD) had its "sell (e)" rating reaffirmed by analysts at
Weiss Ratings.